Literature DB >> 12482459

Inhibition of LPS-induced NO production by the oleogum resin of Commiphora wightii and its constituents.

Meselhy R Meselhy1.   

Abstract

Three new (1-3) and five known compounds (4-8) were isolated from the oleogum resin of Commiphora wightii (Arnott.) Bhanol. Their structures were elucidated by spectroscopic and chemical methods. The MeOH extract and the EtOAc-sol. fraction were found to demonstrate significant inhibition of NO formation in lipopolysaccharide (LPS)-activated murine macrophages J774.1 in vitro (IC(50) values of 16.4 and 12.8 microg/ml, respectively). When compared with curcumin (IC(50) value of 12.3 microM), Z- and E-Guggulsterones (4 and 5, respectively) were the most potent inhibitors of NO production (IC(50) values of 1.1 and 3.3 microM, respectively), followed by myrrhanol A (7) and myrrhanone A (8) (IC(50) values of 21.1 and 42.3 microM, respectively). Guggulsterone-M (1) and its didehydro derivative (2) were weak inhibitors, while guggulsterols I (6) and Y (3) were inactive (IC(50) >500 microM).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482459     DOI: 10.1016/s0031-9422(02)00388-6

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  9 in total

1.  Prevention of endotoxin-induced uveitis in rats by plant sterol guggulsterone.

Authors:  Nilesh M Kalariya; Mohammad Shoeb; Aramati B M Reddy; Min Zhang; Frederik J G M van Kuijk; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-30       Impact factor: 4.799

2.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

3.  Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products.

Authors:  Shishir Shishodia; Gautam Sethi; Kwang Seok Ahn; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2007-03-30       Impact factor: 5.858

4.  Growth inhibition of struvite crystals in the presence of herbal extract Commiphora wightii.

Authors:  C K Chauhan; M J Joshi; A D B Vaidya
Journal:  J Mater Sci Mater Med       Date:  2008-06-21       Impact factor: 3.896

5.  Guggulsterone targets smokeless tobacco induced PI3K/Akt pathway in head and neck cancer cells.

Authors:  Muzafar A Macha; Ajay Matta; Shyam Singh Chauhan; K W Michael Siu; Ranju Ralhan
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

6.  Estimation of Guggulsterone E and Z in the Guggul-based Commercial Formulations Using High-performance Thin-layer Chromatography.

Authors:  Pramod Kumar Sairkar; Anjana Sharma; N P Shukla
Journal:  J Pharm Bioallied Sci       Date:  2017 Jan-Mar

Review 7.  Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases.

Authors:  Ajaikumar B Kunnumakkara; Kishore Banik; Devivasha Bordoloi; Choudhary Harsha; Bethsebie L Sailo; Ganesan Padmavathi; Nand K Roy; Subash C Gupta; Bharat B Aggarwal
Journal:  Front Pharmacol       Date:  2018-08-06       Impact factor: 5.810

8.  Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro.

Authors:  Wen-Ching Wang; Yih-Huei Uen; Ming-Long Chang; Khoot-Peng Cheah; Joe-Sharg Li; Wen-Yu Yu; Kock-Chee Lee; Cheuk-Sing Choy; Chien-Ming Hu
Journal:  BMC Complement Altern Med       Date:  2012-08-27       Impact factor: 3.659

9.  SCAR Marker for Identification and Discrimination of Commiphora wightii and C. myrrha.

Authors:  Pramod Kumar Sairkar; Anjana Sharma; N P Shukla
Journal:  Mol Biol Int       Date:  2016-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.